BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7856263)

  • 1. [Humoral autoimmune response to nuclear Sp100 autoantigen in patients with primary biliary cirrhosis].
    Szostecki C; Will H; Guldner HH
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):573-8. PubMed ID: 7856263
    [No Abstract]   [Full Text] [Related]  

  • 2. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
    Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
    Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis.
    Züchner D; Sternsdorf T; Szostecki C; Heathcote EJ; Cauch-Dudek K; Will H
    Hepatology; 1997 Nov; 26(5):1123-30. PubMed ID: 9362351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis.
    Guldner HH; Szostecki C; Grötzinger T; Will H
    J Immunol; 1992 Dec; 149(12):4067-73. PubMed ID: 1281200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic tests: Anti-Sp100 antibody].
    Mori S; Wake H; Takahashi HK; Nishibori M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():640-2. PubMed ID: 16111356
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis.
    Szostecki C; Guldner HH; Netter HJ; Will H
    J Immunol; 1990 Dec; 145(12):4338-47. PubMed ID: 2258622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against "nuclear dots" in primary biliary cirrhosis.
    Szostecki C; Guldner HH; Will H
    Semin Liver Dis; 1997 Feb; 17(1):71-8. PubMed ID: 9089912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-Sp100 and anti-Gp210 in the diagnosis of primary biliary cirrhosis in patients with autoimmune cholangitis].
    Romero Gómez M; Wichmann I; Otero Fernández MA; Suárez García E; Grande L; Núñez J; Nevado Santos M; Castro Fernández M
    Gastroenterol Hepatol; 1999 Jan; 22(1):11-3. PubMed ID: 10089705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-Sp100 antibody].
    Mori S; Wake H; Liu K; Takahashi HK; Nishibori M
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():711-3. PubMed ID: 20942171
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nuclear antilamin antibodies in primary biliary cirrhosis. A new serological marker].
    Casillas A; Cassinello C; Crespo L; de Juan MD
    Rev Clin Esp; 1990 Oct; 187(6):307. PubMed ID: 2091097
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibodies from patients with primary biliary cirrhosis recognize a region within the nucleoplasmic domain of inner nuclear membrane protein LBR.
    Lin F; Noyer CM; Ye Q; Courvalin JC; Worman HJ
    Hepatology; 1996 Jan; 23(1):57-61. PubMed ID: 8550049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.
    Courvalin JC; Lassoued K; Bartnik E; Blobel G; Wozniak RW
    J Clin Invest; 1990 Jul; 86(1):279-85. PubMed ID: 2195063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anti-multiple nuclear dots/Sp100 autoantibodies.
    Wichmann I; Montes-Cano MA; Respaldiza N; Alvarez A; Walter K; Franco E; Sanchez-Roman J; Núñez-Roldán A
    Scand J Gastroenterol; 2003 Sep; 38(9):996-9. PubMed ID: 14531539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical relevance of autoantibodies in chronic liver diseases].
    Klein R; Berg PA
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):567-72. PubMed ID: 7856262
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis.
    Mytilinaiou MG; Meyer W; Scheper T; Rigopoulou EI; Probst C; Koutsoumpas AL; Abeles D; Burroughs AK; Komorowski L; Vergani D; Bogdanos DP
    Clin Chim Acta; 2012 Aug; 413(15-16):1211-6. PubMed ID: 22503841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is prevalence of PBC underestimated in patients with systemic sclerosis?
    Norman GL; Bialek A; Encabo S; Butkiewicz B; Wiechowska-Kozlowska A; Brzosko M; Shums Z; Milkiewicz P
    Dig Liver Dis; 2009 Oct; 41(10):762-4. PubMed ID: 19357001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinuclear antibodies specific for primary biliary cirrhosis.
    Worman HJ; Courvalin JC
    Autoimmun Rev; 2003 Jun; 2(4):211-7. PubMed ID: 12848948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of autoantibodies against recombinant mitochondrial and nuclear pore proteins after orthotopic liver transplantation for primary biliary cirrhosis.
    Mattalia A; Lüttig B; Rosina F; Leung PS; Van de Water J; Bauducci M; Ciancio A; Böker KH; Worman H; Cooper RL; Manns M; Ansari A; Rizzetto M; Gershwin ME
    J Autoimmun; 1997 Oct; 10(5):491-7. PubMed ID: 9376077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution.
    Szostecki C; Will H; Netter HJ; Guldner HH
    Scand J Immunol; 1992 Oct; 36(4):555-64. PubMed ID: 1384113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-gp210 antibodies in sera of patients with primary biliary cirrhosis. Identification of a 64 kD fragment of gp210 as a major epitope.
    Wesierska-Gadek J; Hohenauer H; Hitchman E; Penner E
    Hum Antibodies Hybridomas; 1996; 7(4):167-74. PubMed ID: 9140728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.